Document is current
Any future updates will be listed below
-
Authors
Carlsson, Lena MS https://orcid.org/0000-0003-4145-6242
Peltonen, Markku https://orcid.org/0000-0002-3767-4223
Jacobson, Peter https://orcid.org/0000-0002-1769-1827
Andersson-Assarsson, Johanna C https://orcid.org/0000-0001-9082-8589
Svensson, Per-Arne https://orcid.org/0000-0002-6731-806X
Taube, Magdalena https://orcid.org/0000-0002-7944-9673
Karlsson, Cecilia https://orcid.org/0000-0002-4299-8775
Ahlin, Sofie https://orcid.org/0000-0003-0619-2683
Kristensson, Felipe M https://orcid.org/0000-0002-9328-4262
Perkins, Rosie
Arnetorp, Ida https://orcid.org/0009-0004-6100-2488
Carlsson, Alexander
Admeus, Lucas https://orcid.org/0009-0008-5179-5751
Langegård, Elin https://orcid.org/0009-0007-5255-7387
Carlsson, Björn
Sjöholm, Kajsa https://orcid.org/0000-0003-0146-8193
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 22 April 2025
First Online: 12 May 2025
Declarations
:
: Seven regional ethics review boards in Sweden approved the study protocol (Gothenburg, Linköping, Skåne, Stockholm, Umeå, Uppsala and Örebro). All the procedures performed were in accordance with the standards of the ethical committees and with the 1964 Helsinki declaration.
: Written or oral informed consent was obtained from all participants.
: B.C. and C.K. are employed by AstraZeneca and hold stocks in the same company. No other conflict of interest was reported.
